Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation

Journal of Immunology

Volumn 168, Issue 12, 2002, Pages 6404-6411

  Berlato, Chiara ^a   Cassatella, Marco A ^a   Kinjyo, Ichiko ^a   Gatto, Luana ^a   Yoshimura, Akihiko ^a   Bazzoni, Flavia ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE DISRUPTION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0037097509     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.12.6404     Document Type: Article

References (44)

1. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi
2. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia
3. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
4. Interleukin 10 protects mice from lethal endotoxemia
5. Interleukin 10-deficient mice develop chronic enterocolitis
6. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses
7. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance
8. Interleukin-10 and the interleukin-10 receptor
9. The neutrophil: One of the cellular targets of interleukin-10
10. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells
11. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10
12. Interleukin-10 inhibits expression of both interferon alpha- and interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1
13. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation
14. Negative regulation of cytokine signaling pathways
15. Negative regulation of cytokine signaling
16. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes
17. Cloning and characterization of novel CIS family genes
18. SOCS3 is essential in the regulation of fetal liver erythropoiesis
19. Up-regulation of IL-10R expression is required to render human neutrophils fully responsive to IL-10
20. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
21. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways
22. Interleukin-10 receptor signaling through the JAK-STAT pathway: Requirement for two distinct receptor-derived signals for anti-inflammatory action
23. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation
24. LPS induction of gene expression in human monocytes
25. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages
26. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells
27. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
28. The inhibition of interleukin-6-dependent STAT activation by mitogenactivated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
29. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
30. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation
31. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
32. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
33. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
34. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology
35. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
36. TNF-α induction by LPS is regulated posttranscriptionally via a Tp12/ERK-dependent pathway
37. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation: Glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK
38. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
39. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10
40. Cutting edge: Clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages
41. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor beta and interleukin-10
42. Interleukin 10 (IL-10) inhibits cytokines synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
43. IL-10-mediated suppression of TNF-α production is independent of its ability to inhibit NFκB activity
44. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases